Application 018248

Type
NDA
Sponsor
FRESENIUS KABI USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OXYTOCINOXYTOCININJECTABLE;INJECTION10USP UNITS/ML (10USP UNITS/ML)YesYes
002OXYTOCINOXYTOCININJECTABLE;INJECTION100USP UNITS/10ML (10USP UNITS/ML)YesYes
003OXYTOCINOXYTOCININJECTABLE;INJECTION300USP UNITS/30ML (10USP UNITS/ML)YesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
55154-9356OxytocinOXYTOCINCardinal HealthNDACurrent
55154-9577OxytocinOXYTOCINCardinal HealthNDACurrent
55154-9577OxytocinOXYTOCINCardinal HealthNDACurrent
55154-9584OxytocinOXYTOCINCardinal HealthNDACurrent
55154-9584OxytocinOXYTOCINCardinal Health 107, LLCNDACurrent
63323-012OxytocinOXYTOCINFresenius Kabi USA, LLCNDACurrent
63323-012OxytocinOXYTOCINFresenius Kabi USA, LLCNDACurrent
63323-012OxytocinOXYTOCINAPP Pharmaceuticals, LLCNDACurrent
63323-012OxytocinOXYTOCINFresenius Kabi USA, LLCNDACurrent
63323-012OxytocinOXYTOCINFresenius Kabi USA, LLCNDACurrent
63323-012OxytocinOXYTOCINFresenius Kabi USA, LLCNDACurrent
63323-012OxytocinOXYTOCINFresenius Kabi USA, LLCNDACurrent
63323-012OxytocinOXYTOCINFresenius Kabi USA, LLCNDACurrent
63323-012OxytocinOXYTOCINFresenius Kabi USA, LLCNDACurrent
63323-012OxytocinOXYTOCINFresenius Kabi USA, LLCNDACurrent
63323-012OxytocinOXYTOCINFresenius Kabi USA, LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
72125SUPPL2022-09-21
72123SUPPL2022-09-21
14958SUPPL2007-07-30
20119SUPPL2007-07-09
20118SUPPL2007-07-09